Paul Haluska Selected Research

BMS 536924

1/2011	Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
10/2009	Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.
9/2008	HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Haluska Research Topics

Disease

52	Neoplasms (Cancer) 01/2022 - 01/2006
17	Breast Neoplasms (Breast Cancer) 10/2021 - 09/2008
16	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 09/2008
7	Carcinoma (Carcinomatosis) 04/2020 - 06/2007
5	Hyperglycemia 10/2021 - 10/2007
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2006
3	Ovarian Epithelial Carcinoma 12/2013 - 07/2011
3	Carcinogenesis 12/2013 - 06/2012
3	Fatigue 03/2010 - 10/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 06/2011
2	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 06/2012
2	Sarcoma (Soft Tissue Sarcoma) 10/2014 - 02/2010
2	Disease Progression 06/2014 - 05/2009
2	Prostatic Neoplasms (Prostate Cancer) 12/2013 - 06/2007
2	Anorexia 03/2010 - 10/2007
2	Nausea 03/2010 - 10/2007
2	Diarrhea 11/2009 - 10/2007
1	Pathologic Complete Response 10/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2020
1	Extranodal Extension 01/2020
1	Adenocarcinoma 01/2020
1	Infections 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Lymphoma (Lymphomas) 08/2017
1	Scrapie 10/2016

Drug/Important Bio-Agent (IBA)

11	Insulin-Like PeptidesIBA 10/2016 - 06/2007
9	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2010
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2007
8	Hormones (Hormone)IBA 10/2021 - 06/2007
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 05/2009
7	Insulin ReceptorIBA 01/2016 - 01/2006
6	Carboplatin (JM8)FDA LinkGeneric 04/2020 - 05/2009
6	figitumumabIBA 03/2010 - 06/2007
5	PlatinumIBA 01/2017 - 07/2011
5	Monoclonal AntibodiesIBA 06/2015 - 10/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2013
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2021 - 01/2015
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2016 - 06/2007
4	Insulin-Like Growth Factor I (IGF-1)IBA 05/2013 - 09/2008
4	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2010 - 10/2007
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 12/2013
3	Lapatinib (GW572016)FDA Link 07/2021 - 07/2011
3	cixutumumabIBA 07/2021 - 05/2013
3	Gemcitabine FDA Link 01/2020 - 06/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 04/2015
3	Estrogen ReceptorsIBA 01/2017 - 06/2012
3	Letrozole (Femara)FDA LinkGeneric 01/2017 - 12/2011
3	Tamoxifen FDA LinkGeneric 03/2016 - 12/2011
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2009
3	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2016 - 01/2006
3	tanespimycin (17AAG)IBA 02/2012 - 11/2010
3	BMS 536924IBA 01/2011 - 09/2008
3	Phosphotransferases (Kinase)IBA 11/2010 - 01/2006
2	cediranib (AZD2171)IBA 01/2022 - 12/2013
2	niraparibIBA 09/2021 - 11/2016
2	Trastuzumab (Herceptin)FDA Link 07/2021 - 07/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 03/2012
2	RNA (Ribonucleic Acid)IBA 10/2018 - 07/2017
2	veliparibIBA 01/2018 - 01/2015
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2018 - 07/2011
2	Estrogen Receptor alphaIBA 07/2017 - 10/2016
2	Aromatase InhibitorsIBA 10/2016 - 03/2016
2	CytokinesIBA 03/2016 - 11/2009
2	Tyrosine Kinase InhibitorsIBA 07/2015 - 12/2011
2	Insulin (Novolin)FDA Link 01/2015 - 10/2009
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 05/2013 - 03/2010
2	temsirolimus FDA Link 05/2013 - 10/2012
2	Estrogens (Estrogen)FDA Link 12/2012 - 12/2011
2	Antineoplastic Agents (Antineoplastics)IBA 12/2011 - 07/2009
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2010 - 10/2007
2	BMS-554417IBA 09/2008 - 01/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	AZD 6244IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	ganitumabIBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	rucaparibIBA 09/2021
1	Capecitabine (Xeloda)FDA Link 07/2021
1	romidepsin (FK228)FDA Link 10/2020
1	GlycogenIBA 04/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	HhAntag691IBA 01/2020
1	AntibodiesIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	ZirconiumIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Janus Kinase InhibitorsIBA 10/2018
1	ruxolitinibIBA 10/2018
1	InterferonsIBA 10/2018
1	Rituximab (Mabthera)FDA Link 08/2017
1	Dihydrotachysterol (AT 10)IBA 07/2017
1	Everolimus FDA Link 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2016

Therapy/Procedure

26	Therapeutics 10/2021 - 07/2008
13	Drug Therapy (Chemotherapy) 07/2021 - 06/2007
1	Neoadjuvant Therapy 10/2021
1	Oncolytic Virotherapy 10/2018